Sutro Biopharma names Lucas Donigian SVP, business development

Bitget2026/09/29 12:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sutro Biopharma appointed Lucas Donigian as senior vice president, business development, effective Sept. 28, 2026.
Donigian previously served as vice president, head of business development and licensing and commercial at Zymeworks.
Earlier roles include director of business development and biopharma collaboration at NanoString Technologies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sutro Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290800PRIMZONEFULLFEED9835576) on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sutro Biopharma names Lucas Donigian SVP, business development

You may also like

Crypto prices